This is a preview of subscription content, log in via an institution to check access.
Literatur
Semmler G, Binter T, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, et al. Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease. Hepatology. 2020;73(4):1275–89.
Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, et al. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology. 2020;71(3):1023–36.
Semmler G, Scheiner B, Schwabl P, Bucsics T, Paternostro R, Chromy D, et al. The impact of hepatic steatosis on portal hypertension. PLoS ONE. 2019;14(11):e224506.
Stift J, Semmler G, Wöran K, Simbrunner B, Scheiner B, Schwabl P, et al. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy. Dig Liver Dis. 2020;52(12):1473–79.
Semmler G, Stift J, Scheiner B, Woran K, Schwabl P, Paternostro R, et al. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Dig Dis Sci. 2019;64(12):3642–51.
Semmler G, Wöran K, Scheiner B, Unger LW, Paternostro R, Stift J, et al. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United European Gastroenterol j. 2020;8(3):321–31.
Wöran K, Semmler G, Jachs M, Simbrunner B, Bauer MDJ, Binter T, et al. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol. 2020;S1542-3565(20)31629-3.
Semmler G, Binter T, Kozbial K, Schwabl P, Chromy D, Bauer D, et al. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. J Pers Med. 2021;11(4):281.
Semmler G, Griebler H, Aberle SW, Stiasny K, Richter L, Holzmann H, et al. Elevated CXCL10 Serum Levels in Measles Virus Primary Infection and Reinfection Correlate With the Serological Stage and Hospitalization Status. J INFECT DIS. 2020;222(12):2030–4.
Semmler G, Traugott MT, Graninger M, Hoepler W, Seitz T, Kelani H, et al. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021;59(5):e02890–20.
Semmler G, Aberle SW, Griebler H, Richter L, Schmid D, Stiasny K, et al. Performance of Four IgM Antibody Assays in the Diagnosis of Measles Virus Primary Infection and Cases with a Serological Profile Indicating Reinfection. J Clin Microbiol. 2021;59(5):e02047–20.
Semmler G, Bachmayer S, Wernly S, Wernly B, Niederseer D, Huber-Schönauer U, et al. Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. PLoS ONE. 2020;15(12):e244514.
Semmler G, Wernly S, Bachmayer S, Wernly B, Schwenoha L, Huber-Schönauer U, et al. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study. Clin Transl Gastroenterol. 2021;12(4):e326.
Semmler G, Wernly S, Bachmayer S, Leitner I, Wernly B, Egger M, et al. Metabolic dysfunction-associated fatty liver disease (MAFLD) - rather a bystander than a driver of mortality. J Clin Endocrinol Metab. 2021.https://doi.org/10.1210/clinem/dgab339.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
MUW researcher of the month. Wien Klin Wochenschr 133, 994–995 (2021). https://doi.org/10.1007/s00508-021-01951-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-021-01951-7